Michael J. Zigmond

From Wikipedia, the free encyclopedia

Michael. J. Zigmond is an American neuroscientist. He is emeritus Professor of Neurology at University of Pittsburgh since 2017, previously Professor of Neurology, Psychiatry, and Pharmacology, and Editor-in-Chief of Elsevier's Progress in Neurobiology.[1] He is an Elected Fellow, since 2009, of the American Association for the Advancement of Science.[2] His interests include neuroprotection and neuroplasticity, health aging, and Parkinson's disease.[3] Since 2011, he has also served as Distinguished International Professor at Fudan University.[4]

Education[]

He earned his B.S. in chemical engineering at Carnegie-Mellon University and Ph.D. in biopsychology at University of Chicago in 1968.[4]

Selected publications[]

  • "Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor". Cell. 96 (6): 857–868. 1999-03-19. doi:10.1016/S0092-8674(00)80595-4. ISSN 0092-8674.
  • Dishman, Rod K.; Berthoud, Hans-Rudolf; Booth, Frank W.; Cotman, Carl W.; Edgerton, V. Reggie; Fleshner, Monika R.; Gandevia, Simon C.; Gomez‐Pinilla, Fernando; Greenwood, Benjamin N.; Hillman, Charles H.; Kramer, Arthur F.; Zigmond, Michael J. (2006). "Neurobiology of Exercise". Obesity. 14 (3): 345–356. doi:10.1038/oby.2006.46. ISSN 1930-739X.

References[]

  1. ^ "Michael J. Zigmond". elsevier.com. Retrieved December 8, 2017.
  2. ^ "Michael J. Zigmond". aaas.org. Retrieved December 8, 2017.
  3. ^ "Michael J. Zigmond". pitt.edu. Retrieved December 8, 2017.
  4. ^ Jump up to: a b "Lab". pitt.edu. Retrieved December 8, 2017.
Retrieved from ""